These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets. Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599 [TBL] [Abstract][Full Text] [Related]
3. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model. Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071 [TBL] [Abstract][Full Text] [Related]
4. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination. Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424 [TBL] [Abstract][Full Text] [Related]
5. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
6. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma. Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis. Oda Y; Suzuki R; Otake S; Nishiie N; Hirata K; Koshima R; Nomura T; Utoguchi N; Kudo N; Tachibana K; Maruyama K J Control Release; 2012 Jun; 160(2):362-6. PubMed ID: 22192573 [TBL] [Abstract][Full Text] [Related]
8. [Systemic delivery of complexes of melanoma RNA with mannosylated liposomes activates highly efficient murine melanoma-specific cytotoxic T cells in vivo]. Markov OV; Mironova NL; Shmendel EV; Maslov MA; Zenkova MA Mol Biol (Mosk); 2017; 51(1):118-125. PubMed ID: 28251974 [TBL] [Abstract][Full Text] [Related]
9. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier. Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M Mol Pharm; 2011 Apr; 8(2):543-54. PubMed ID: 21250746 [TBL] [Abstract][Full Text] [Related]
10. Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice. DeMatos P; Abdel-Wahab Z; Vervaert C; Hester D; Seigler H J Surg Oncol; 1998 Jun; 68(2):79-91. PubMed ID: 9624036 [TBL] [Abstract][Full Text] [Related]
11. Efficient responses in a murine renal tumor model by electroloading dendritic cells with whole-tumor lysate. Weiss JM; Allen C; Shivakumar R; Feller S; Li LH; Liu LN J Immunother; 2005; 28(6):542-50. PubMed ID: 16224271 [TBL] [Abstract][Full Text] [Related]
12. Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines. Wang Y; Zenkoh J; Gerelchuluun A; Sun L; Cai S; Li X; Tsuboi K Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):958-969. PubMed ID: 30458232 [TBL] [Abstract][Full Text] [Related]
13. Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model. Mac Keon S; Bentivegna S; Levy EM; Marks MS; Mantegazza AR; Wainstok R; Mordoh J Vaccine; 2019 Aug; 37(35):4947-4955. PubMed ID: 31307876 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses. Zheng H; Liu L; Zhang H; Kan F; Wang S; Li Y; Tian H; Meng S PLoS One; 2019; 14(1):e0211490. PubMed ID: 30703157 [TBL] [Abstract][Full Text] [Related]
16. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin. Zhang W; He L; Yuan Z; Xie Z; Wang J; Hamada H; Cao X Hum Gene Ther; 1999 May; 10(7):1151-61. PubMed ID: 10340547 [TBL] [Abstract][Full Text] [Related]
17. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma. Aravindaram K; Wang PH; Yin SY; Yang NS Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790 [TBL] [Abstract][Full Text] [Related]
18. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
19. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. Wang J; Saffold S; Cao X; Krauss J; Chen W J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528 [TBL] [Abstract][Full Text] [Related]
20. A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]